Gal Oren, Feldman Dan, Mari Amir, Baker Fadi Abu, Hebron Dan, Kopelman Yael
Gastroenterology Department, Hillel Yaffe Medical Center, Hashalom Street, Hadera, Israel.
Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel.
J Gastrointest Cancer. 2020 Mar;51(1):130-134. doi: 10.1007/s12029-019-00220-1.
Rectal cancer represents a leading cause of mortality worldwide. Staging defines the local and distant extent of the disease, guides management, and predicts prognosis. Different modalities are available for staging including TRUS (transrectal ultrasound), CT (computed tomography), and MRI (magnetic resonance imaging).
The objective of this study was to screen and isolate CT imaging parameters suggestive of advanced rectal cancer and its utility as a tool in simplifying the staging protocol making further imaging studies unnecessary.
Retrospective, single center study.
Seventy-five patients with rectal carcinoma were included and were divided into two groups according to their T score and nodal involvement status, as diagnosed by TRUS. Group 1 (n = 15) "local disease" (T1/T2 N0) and group 2 (n = 60) "locally advanced disease" are both eligible for neoadjuvant treatment (N/any T or T3/any N). For each patient, three CT imaging parameters that represent locally advanced disease, i.e., perirectal fat infiltration, local lymphadenopathy, and rectal wall thickening, were evaluated and compared between the two groups.
The capability of CT imaging to accurately predict locally advanced rectal carcinoma.
Rectal wall thickening on CT was found to have 92% PPV and perirectal lymphadenopathy 96% PPV for predicting a locally advanced stage. A combination of those two parameters results in a predictive PPV of 98%.
This was a single center retrospective study, with a relatively small cohort.
CT is a valuable tool in the assessment and management of rectal carcinoma as it can identify locally advanced rectal cancer. This enables treatment without any further unnecessary evaluation.
直肠癌是全球主要的致死原因之一。分期可明确疾病的局部和远处范围,指导治疗并预测预后。有多种分期方式,包括经直肠超声(TRUS)、计算机断层扫描(CT)和磁共振成像(MRI)。
本研究的目的是筛选并分离出提示晚期直肠癌的CT成像参数,以及评估其作为简化分期方案工具的效用,从而无需进行进一步的影像学检查。
回顾性单中心研究。
纳入75例直肠癌患者,根据经直肠超声诊断的T评分和淋巴结受累情况分为两组。第1组(n = 15)为“局部疾病”(T1/T2 N0),第2组(n = 60)为“局部晚期疾病”,两组均适合新辅助治疗(N/任何T或T3/任何N)。对每位患者,评估并比较代表局部晚期疾病的三个CT成像参数,即直肠周围脂肪浸润、局部淋巴结肿大和直肠壁增厚。
CT成像准确预测局部晚期直肠癌的能力。
发现CT上的直肠壁增厚预测局部晚期阶段的阳性预测值(PPV)为92%,直肠周围淋巴结肿大的PPV为96%。这两个参数联合使用时预测PPV为98%。
这是一项单中心回顾性研究,队列相对较小。
CT是评估和管理直肠癌的有价值工具,因为它可以识别局部晚期直肠癌。这使得无需进行任何进一步不必要的评估即可进行治疗。